August 1, 2008 – BSD Medical Corp. said its BSD-2000/3D/MR cancer treatment system has been adapted to treat children with cancer.
To accommodate the treatment of children, BSD has developed treatment applications specifically sized for small and medium-sized children and that are capable of delivering pediatric cancer therapy during simultaneous magnetic resonance imaging (MRI) during the treatment process.
The BSD-2000/3D/MR was developed by BSD and Siemens Medical Solutions. Initial targets for treatment of children’s cancers include germ cell tumors and soft tissue sarcomas.
BSD said it's currently shipping a Sigma 40/MR pediatric applicator to Erlangen University Medical School in Germany, an applicator that will be an upgrade to the BSD-2000/3D/MR system.
For more information: www.bsdmc.com